Dale Han

1.5k total citations
49 papers, 934 citations indexed

About

Dale Han is a scholar working on Oncology, Epidemiology and Molecular Biology. According to data from OpenAlex, Dale Han has authored 49 papers receiving a total of 934 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 19 papers in Epidemiology and 16 papers in Molecular Biology. Recurrent topics in Dale Han's work include Cutaneous Melanoma Detection and Management (37 papers), Nonmelanoma Skin Cancer Studies (19 papers) and Melanoma and MAPK Pathways (14 papers). Dale Han is often cited by papers focused on Cutaneous Melanoma Detection and Management (37 papers), Nonmelanoma Skin Cancer Studies (19 papers) and Melanoma and MAPK Pathways (14 papers). Dale Han collaborates with scholars based in United States, Israel and Italy. Dale Han's co-authors include Jonathan S. Zager, Vernon K. Sondak, Gang Han, Jane L. Messina, Suroosh S. Marzban, John T. Vetto, Barbara A. Pockaj, Stanley P. L. Leong, Richard L. White and Mohammed Kashani–Sabet and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Dale Han

49 papers receiving 918 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dale Han United States 18 785 289 248 185 110 49 934
Andrew J. Sinnamon United States 17 453 0.6× 386 1.3× 165 0.7× 96 0.5× 35 0.3× 47 932
Cécile Pagès France 19 794 1.0× 302 1.0× 188 0.8× 232 1.3× 41 0.4× 53 1.1k
Florentia Dimitriou Switzerland 16 665 0.8× 250 0.9× 133 0.5× 230 1.2× 161 1.5× 50 936
Wanda Michej Poland 14 509 0.6× 224 0.8× 181 0.7× 79 0.4× 39 0.4× 21 1.0k
L. Peuvrel France 19 493 0.6× 280 1.0× 186 0.8× 152 0.8× 244 2.2× 63 853
Alexander H. R. Varey Australia 15 360 0.5× 504 1.7× 80 0.3× 65 0.4× 20 0.2× 44 862
Yuko Sasajima Japan 19 375 0.5× 358 1.2× 240 1.0× 44 0.2× 121 1.1× 94 1.2k
Vito Vanella Italy 16 709 0.9× 328 1.1× 58 0.2× 267 1.4× 23 0.2× 34 997
Junko Ozao‐Choy United States 14 710 0.9× 237 0.8× 110 0.4× 693 3.7× 20 0.2× 48 1.3k
Lorenza Di Guardo Italy 15 987 1.3× 360 1.2× 75 0.3× 398 2.2× 25 0.2× 48 1.2k

Countries citing papers authored by Dale Han

Since Specialization
Citations

This map shows the geographic impact of Dale Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dale Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dale Han more than expected).

Fields of papers citing papers by Dale Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dale Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dale Han. The network helps show where Dale Han may publish in the future.

Co-authorship network of co-authors of Dale Han

This figure shows the co-authorship network connecting the top 25 collaborators of Dale Han. A scholar is included among the top collaborators of Dale Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dale Han. Dale Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Han, Gang, John T. Vetto, Graham Fowler, et al.. (2022). Is the presence of tumor‐infiltrating lymphocytes predictive of outcomes in patients with melanoma?. Cancer. 128(7). 1418–1428. 3 indexed citations
2.
Vitiello, Gerardo A., Erica B. Friedman, James Sun, et al.. (2021). Acral Lentiginous Melanoma: A United States Multi-Center Substage Survival Analysis. Cancer Control. 28. 2895471615–2895471615. 16 indexed citations
3.
Han, Dale, Alexander C. J. van Akkooi, Richard J. Straker, et al.. (2021). Current management of melanoma patients with nodal metastases. Clinical & Experimental Metastasis. 39(1). 181–199. 8 indexed citations
4.
Han, Gang, Stanley P. L. Leong, Mohammed Kashani–Sabet, et al.. (2021). Regression is significantly associated with outcomes for patients with melanoma. Surgery. 170(5). 1487–1494. 8 indexed citations
5.
Han, Dale, et al.. (2020). Relationship of patient age to tumor factors and outcomes among patients undergoing sentinel node biopsy for melanoma. The American Journal of Surgery. 219(5). 836–840. 6 indexed citations
6.
Han, Dale, Gang Han, Stanley P. L. Leong, et al.. (2020). Sentinel Lymph Node Biopsy Is Prognostic in Thickest Melanoma Cases and Should Be Performed for Thick Melanomas. Annals of Surgical Oncology. 28(2). 1007–1016. 12 indexed citations
7.
Han, Dale, Gang Han, Stanley P. L. Leong, et al.. (2020). Factors predicting survival in thick melanoma: Do all thick melanomas have the same prognosis?. Surgery. 168(3). 518–526. 10 indexed citations
8.
Zager, Jonathan S., Amod Sarnaik, Shari Pilon‐Thomas, et al.. (2020). 1123P A phase Ib study of rose bengal disodium and anti-PD-1 in metastatic cutaneous melanoma: Initial results in patients refractory to checkpoint blockade. Annals of Oncology. 31. S755–S756. 4 indexed citations
9.
Hersh, Alyssa R., et al.. (2020). What is the Cost-Effective Treatment for Melanoma Patients with a Positive Sentinel Node?. Annals of Surgical Oncology. 28(5). 2913–2922. 3 indexed citations
10.
Klemen, Nicholas D., Gang Han, Stanley P. L. Leong, et al.. (2019). Completion lymphadenectomy for a positive sentinel node biopsy in melanoma patients is not associated with a survival benefit. Journal of Surgical Oncology. 119(8). 1053–1059. 12 indexed citations
11.
Pavri, Sabrina, Gang Han, Sajid Khan, & Dale Han. (2019). Does sentinel lymph node status have prognostic significance in patients with acral lentiginous melanoma?. Journal of Surgical Oncology. 119(8). 1060–1069. 13 indexed citations
12.
Klemen, Nicholas D., Melinda Wang, Paul L. Feingold, et al.. (2019). Patterns of failure after immunotherapy with checkpoint inhibitors predict durable progression-free survival after local therapy for metastatic melanoma. Journal for ImmunoTherapy of Cancer. 7(1). 196–196. 54 indexed citations
13.
Thomas, Daniel C., Gang Han, Stanley P. L. Leong, et al.. (2019). Recurrence of Melanoma After a Negative Sentinel Node Biopsy: Predictors and Impact of Recurrence Site on Survival. Annals of Surgical Oncology. 26(7). 2254–2262. 27 indexed citations
14.
Miccio, Joseph A., Vikram Jairam, Sarah Gao, et al.. (2019). Predictors of Lymph Node Involvement by Soft Tissue Sarcoma of the Trunk and Extremity: An Analysis of the National Cancer Database. Cureus. 11(10). e6038–e6038. 13 indexed citations
15.
Pavri, Sabrina, et al.. (2018). Nonvisualization of Sentinel Lymph Nodes by Lymphoscintigraphy in Primary Cutaneous Melanoma: Incidence, Risk Factors, and a Review of Management Options. Plastic & Reconstructive Surgery. 142(4). 527e–534e. 5 indexed citations
16.
Murtha, Timothy D., Gang Han, & Dale Han. (2018). Predictors for Use of Sentinel Node Biopsy and the Association with Improved Survival in Melanoma Patients Who Have Nodal Staging. Annals of Surgical Oncology. 25(4). 903–911. 31 indexed citations
17.
Han, Dale, Jonathan S. Zager, Yu Shyr, et al.. (2013). Clinicopathologic Predictors of Sentinel Lymph Node Metastasis in Thin Melanoma. Journal of Clinical Oncology. 31(35). 4387–4393. 161 indexed citations
18.
Han, Dale, Georgia M. Beasley, Douglas S. Tyler, & Jonathan S. Zager. (2011). Minimally invasive intra-arterial regional therapy for metastatic melanoma: isolated limb infusion and percutaneous hepatic perfusion. Expert Opinion on Drug Metabolism & Toxicology. 7(11). 1383–1394. 5 indexed citations
19.
Sondak, Vernon K., Dale Han, Jeremiah L. Deneve, & Ragini R. Kudchadkar. (2011). Current and planned multicenter trials for patients with primary or metastatic melanoma. Journal of Surgical Oncology. 104(4). 430–437. 7 indexed citations
20.
Murashima, Miho, Scott O. Trerotola, Douglas L. Fraker, et al.. (2009). Adrenal Venous Sampling for Primary Aldosteronism and Clinical Outcomes After Unilateral Adrenalectomy: A Single‐Center Experience. Journal of Clinical Hypertension. 11(6). 316–323. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew J. Sinnamon Breakdown of academic impact, for papers by Cécile Pagès Breakdown of academic impact, for papers by Florentia Dimitriou Breakdown of academic impact, for papers by Wanda Michej Breakdown of academic impact, for papers by L. Peuvrel Breakdown of academic impact, for papers by Alexander H. R. Varey Breakdown of academic impact, for papers by Yuko Sasajima Breakdown of academic impact, for papers by Vito Vanella Breakdown of academic impact, for papers by Junko Ozao‐Choy Breakdown of academic impact, for papers by Lorenza Di Guardo
Rankless by CCL
2026